SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-22-046091
Filing Date
2022-08-10
Accepted
2022-08-10 08:00:32
Documents
14
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea164114-8ka1_optimize.htm   iXBRL 8-K/A 28296
2 PRESS RELEASE, DATED AUGUST 9, 2022 (CORRECTED) ea164114ex99-1_optimize.htm EX-99.1 127012
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4353
  Complete submission text file 0001213900-22-046091.txt   352838

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20220809.xsd EX-101.SCH 2965
5 XBRL LABEL FILE oprx-20220809_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20220809_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea164114-8ka1_optimize_htm.xml XML 4075
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38543 | Film No.: 221150452
SIC: 7389 Services-Business Services, NEC